Page 10 - David Ricks News Today

A Scottsdale man was arrested for allegedly stabbing his longtime roommate to death on Wednesday, authorities said.

The Indianapolis-based drugmaker, which makes weight-loss drug Zepbound and diabetes drug Mounjaro, recently aired a new 30-second spot, just ahead of the Academy Awards, to underscore the message.

Mounjaro and Zepbound manufacturer Eli Lilly has battled supply issues since weight loss injectables took off. Those who rely on Mounjaro are currently facing shortages and backorders and may be for the foreseeable future.

Weight-loss-related drugs have proliferated in recent years, and Eli Lilly is trying to remind patients how to use them appropriately.

Drugmaker Eli Lilly does not approve of people using their weight loss medications when it is not medically required.

US drug maker Eli Lilly plans to launch its weight-loss drugs Zepbound and Mounjaro in India next year. The company is considering pricing based on supply and volume expansion. Eli Lilly CEO David Ricks suggests focusing on digital services in the Indian healthcare industry to encourage innovation and improve access to healthcare.

At a market cap that exceeds $720 billion, US drug maker Eli Lilly tops the list of worlds most valuable pharmaceutical companies. The key to that is recent US approval for its weight-loss drug Zepbound (tirzepatide).

Eli Lillys CEO David Ricks told Reuters on Wednesday that the U.S. drugmaker expects to launch its obesity drug in Indian market as early as next year.

HYDERABAD (Reuters) -U.S. drugmaker Eli Lilly expects to launch Mounjaro, its blockbuster diabetes drug and a wildly popular obesity treatment, in India as early as next year, CEO David Ricks told Reuters on Wednesday. The market opportunity is huge in the world's most populous country, which has high obesity rates, especially among women, and the second-highest number of people with type-2 diabetes globally. Indian drugmakers are making their own versions of such drugs, while illegal ver...

Eli Lilly expects to launch its obesity drug tirzepatide in India as early as next year, the U.S. drugmakers CEO David Ricks told Reuters on Wednesday. Were open to any way to reach...